⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2018International Journal of COPDOpen Access

Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure

View Full Paper

Ask AI

Bookmark

Share

Abstract

HFNC treatment reduced AECOPD, hospital admissions and symptoms in COPD patients with hypoxic failure.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Storgaard et al. (2018) studied this question.

synapsesocial.com/papers/69d776439c65a8c80448f6ea https://doi.org/10.2147/copd.s159666

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trialCohort Study · 2016 · 202 citations
2High-flow nasal cannula oxygen therapy in adultsOriginal Research · 2015 · 333 citations
3Health-related quality of life and functional status in end-stage COPD: a longitudinal studyCohort Study · 2010 · 57 citations
4Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary diseasePrognostic Study · 2005 · 1,975 citations
5Long-Term Oxygen Therapy Stops the Natural Decline of Endurance in COPD Patients with Reversible HypercapniaCohort Study · 2004 · 67 citations